Ravasi G - Search Results

1

Integration of fungal diseases into health systems in Latin America.

Rodriguez Tudela JL, Cole DC, Ravasi G, Bruisma N, Chiller TC, Ford N, Denning DW. Rodriguez Tudela JL, et al. Among authors: ravasi g. Lancet Infect Dis. 2020 Aug;20(8):890-892. doi: 10.1016/S1473-3099(20)30469-2. Epub 2020 Jun 30. Lancet Infect Dis. 2020. PMID: 32619435 No abstract available.

2

Insights into HIV treatment in Latin America and the Caribbean.

Castro JL, Ravasi G. Castro JL, et al. Among authors: ravasi g. Lancet HIV. 2015 Nov;2(11):e458-9. doi: 10.1016/S2352-3018(15)00205-2. Epub 2015 Oct 22. Lancet HIV. 2015. PMID: 26520923 No abstract available.

3

Summary of Guidelines for Managing Histoplasmosis among People Living with HIV.

Perez F, Caceres DH, Ford N, Ravasi G, Gomez BL, Pasqualotto AC, Hine P, Adenis AA, Nacher M, Chiller T, Baddley J, For The Guideline Development Group For Diagnosing And Managing Disseminated Histoplasmosis Among People Living With Hiv. Perez F, et al. Among authors: ravasi g. J Fungi (Basel). 2021 Feb 12;7(2):134. doi: 10.3390/jof7020134. J Fungi (Basel). 2021. PMID: 33673384 Free PMC article.

4

Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean.

Ravasi G, Jack N, Alonso Gonzalez M, Sued O, Pérez-Rosales MD, Gomez B, Vila M, Riego Ad, Ghidinelli M. Ravasi G, et al. Rev Panam Salud Publica. 2011 Dec;30(6):657-62. doi: 10.1590/s1020-49892011001200026. Rev Panam Salud Publica. 2011. PMID: 22358418

5

HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.

Bennett DE, Jordan MR, Bertagnolio S, Hong SY, Ravasi G, McMahon JH, Saadani A, Kelley KF. Bennett DE, et al. Among authors: ravasi g. Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S280-9. doi: 10.1093/cid/cis207. Clin Infect Dis. 2012. PMID: 22544188 Free PMC article.

6

Implementing early-warning indicators of HIV drug resistance in the Caribbean.

Jack N, Ravasi G, Schrooten W, Sutherland D, Ghidinelli M, Del Riego A. Jack N, et al. Among authors: ravasi g. Clin Infect Dis. 2012 May;54 Suppl 4:S290-3. doi: 10.1093/cid/cir1044. Clin Infect Dis. 2012. PMID: 22544189

7

Progress and challenges in implementing HIV care and treatment policies in Latin America following the treatment 2.0 initiative.

Perez F, Gomez B, Ravasi G, Ghidinelli M. Perez F, et al. Among authors: ravasi g. BMC Public Health. 2015 Dec 19;15:1260. doi: 10.1186/s12889-015-2565-9. BMC Public Health. 2015. PMID: 26686850 Free PMC article.

8

Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.

Godfrey C, Bobkova M, Boucher C, Ravasi G, Chen P, Zhang F, Wu Y, Kantor R. Godfrey C, et al. Among authors: ravasi g. J Infect Dis. 2017 Dec 1;216(suppl_9):S816-S819. doi: 10.1093/infdis/jix408. J Infect Dis. 2017. PMID: 28968824 Free PMC article.

9

Tuberculosis and HIV coinfection and related collaborative activities in Latin America and the Caribbean.

Moreno R, Ravasi G, Avedillo P, Lopez R. Moreno R, et al. Among authors: ravasi g. Rev Panam Salud Publica. 2020 May 22;44:e43. doi: 10.26633/RPSP.2020.43. eCollection 2020. Rev Panam Salud Publica. 2020. PMID: 32440293 Free PMC article.

10

Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis.

Avila-Rios S, Sued O, Rhee SY, Shafer RW, Reyes-Teran G, Ravasi G. Avila-Rios S, et al. Among authors: ravasi g. PLoS One. 2016 Jun 29;11(6):e0158560. doi: 10.1371/journal.pone.0158560. eCollection 2016. PLoS One. 2016. PMID: 27355626 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page